To include your compound in the COVID-19 Resource Center, submit it here.

GLFD reacquires Gliadel rights from AVE

Guilford (GLFD) reacquired worldwide distribution and marketing rights from Aventis (AVE) to its

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE